News

Nanotechnology Engineering Team 18 won this year’s Esch Competition with their project GeneDetek. Team members Karla Castro, Andrea Parra, Sara Thompson, and Nube Torres developed an electrochemical biosensor for genetic mutation detection.

Depression is a complex mental health condition that affects millions worldwide. For many patients, finding an effective treatment can be a daunting challenge, often complicated by adverse side effects of prescription drugs.

Capstone Team 2 had two big wins at this year’s Capstone Design Symposium. They won the Baylis Medical Award along with Team 3. They also won the UN Sustainable Development Goal Award for the Nanotechnology Engineering Program. The team’s project was titled “ A+ Blood Typing”.

This team aimed to address the increasing demand for O-negative blood for blood transfusions. The demand for O-negative blood, also known as the "universal donor" blood type, is high because it can be safely transfused to patients of any blood type in emergency situations. This is critical when there isn't enough time to determine the patient's blood type. O-negative blood use is crucial in trauma situations, where quick transfusions are necessary to save lives.

Cervical cancer is diagnosed in over 1,000 Canadian women each year, and approximately 410 women die from the disease annually. Women need to undergo regular cervical cancer screening, as early detection can significantly increase the chances of successful treatment.

However, in Ontario, women are only eligible for the Pap Test (or Pap smear) every three years. CT Murphy a Nanotechnology Engineering (NE) graduate (BASc ’23) aims to create a new testing method that allows women to screen for the human papillomavirus (HPV) that usually causes cervical cancer.